`
`Year
`
`2009
`
`2010
`
`2011
`
`2012
`
`2013
`
`2014
`
`Total
`
`United States
`
`Worldwide
`
`Sales
`
`Growth
`
`Sales
`
`Growth
`
`
`
`10.8$
`
`
`
`54.7$
`
`
`
`94.0$
`
`
`
`115.2$
`
`
`
`120.0$
`
`
`
`133.0$
`
`
`
`527.7$
`
`n/a
`
`
`
`59.0$
`
`406.5%
`
`
`
`137.0$
`
`71.8%
`
`
`
`187.0$
`
`22.6%
`
`
`
`207.0$
`
`4.2%
`
`
`
`236.0$
`
`10.8%
`
`
`
`288.0$
`
`n/a
`
`
`
`1,114.0$
`
`n/a
`
`132.2%
`
`36.5%
`
`10.7%
`
`14.0%
`
`22.0%
`
`n/a
`
`Notes and sources:
`Monetary values are in millions of $U.S.
`U.S. sales:
`2009–2010: UBS, "U.S. Pharmaceuticals," 8/24/2011, at 86, Table 83.
`2011–2014: UBS, "U.S. Pharmaceuticals," 1/4/2016, at 90, Figure 82.
`Worldwide sales:
`2009–2011: Pfizer Inc., Form 10-K, 2012, at Exhibit 13, p. 21.
`2012–2014: Pfizer Inc., Form 10-K, 2015, at Exhibit 13, p. 21.
`
`Petitioner Torrent Pharmaceuticals Limited - Exhibit 1036 - Page 1